Article Details

Akero Closes $65M Financing to Back Liver Drug Licensed from Amgen

Retrieved on: 2018-06-24 22:26:15

Tags for this article:

Click the tags to see associated articles and topics

Akero Closes $65M Financing to Back Liver Drug Licensed from Amgen. View article details on hiswai:

Excerpt

<div>Xconomy Boston —. New biotech startup Akero Therapeutics debuted Monday with $65 million in a Series A round of funding to advance clinical ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up